One tissue sample: Unlimited knowledge
CARTANA is a Swedish Biotechnology company with the mission of equipping researchers with innovative spatial sequencing technology.
Our technology enables researchers from academia and industry to decipher both functions and diseases of the brain, tumors and other organs to much greater depth than previously possible. CARTANA aims to become the leading facilitator for finding and validating new treatment strategies against major diseases.
Our solution is transversal to multiple scientific fields, namely neuroscience, oncology and immunology, and promotes advancements on cellular and molecular biology, disease diagnostics and treatment development.
Optimized Reagent Kits
Straightforward protocol to identify up to 100 genes in one tissue sample
Send your prepared samples to CARTANA where we will sequence them rapidly with robust results
One step ahead
CARTANA is further developing its in situ sequencing technology and kits for more tissue types
Meet The Team
Board of Directors
Anders Nordström, Chairman
Senior Business Advisor
Mats Nilsson, Ph.D., Professor
Scientific director at SciLifeLab Stockholm
Simon Fredriksson, Ph.D.
CEO Genagon Therapeutics, Former CEO Olink Biosciences
Nina Forsberg, Ph.D., MBA
Marketing Director at Vironova AB
Investment Manager at Almi Invest AB
Sten Linnarsson, Ph.D., Professor
Head of the Single Cell Analysis Facility at SciLifeLab
Jens Hjerling-Leffler, Ph.D.
Associate Professor of Neuroscience at Karolinska Institute
Rongqin Ke, Ph.D., Professor
Thomas Hauling, Ph.D.
University College London
Marco Mignardi, Ph.D.
Biohub CZ San Francisco
Markus Hilscher, Ph.D.
Our Partners & Collaborators
CARTANA is proud to collaborate with the following companies & organizations:
KI Innovations, Novo Nordisk Foundation, SU Innovation, Vinnova & Science for Life Laboratory.
Discover The Future
We are a multi-disciplinary laboratory
committed to the advancement of biology.